Verizon To Rally Around 20%? Here Are 10 Other Analyst Forecasts For Tuesday

Stifel raised the price target for Hersha Hospitality Trust HT from $8.75 to $10. Stifel analyst Simon Yarmak downgraded the stock from Buy to Hold. Hersha Hospitality Trust shares fell 0.5% to $9.74 in pre-market trading.
Citigroup increased Verizon Communications Inc. VZ price target from $39 to $40. Citigroup analyst Michael Rollins upgraded the stock from Neutral to Buy. Verizon shares rose 0.6% to close at $33.55 on Monday.
UBS boosted the price target for Oracle Corporation ORCL from $120 to $140. UBS analyst Karl Keirstead upgraded the stock from Neutral to Buy. Oracle shares rose 0.7% to close at $116.84 on Monday.
Jefferies cut the price target for Forward Air Corporation FWRD from $110 to $85. Jefferies analyst Stephanie Moore upgraded the stock from Hold to Buy. Forward Air shares fell 0.5% to close at $70.89 on Monday.
Piper Sandler slashed Celanese Corporation CE price target from $120 to $112. Piper Sandler analyst Charles Neivert downgraded the stock from Neutral to Underweight. Celanese shares fell 1.6% to $119.65 in pre-market trading.
Wells Fargo boosted Rockwell Automation, Inc. ROK price target from $290 to $317. Wells Fargo analyst Joe O'Dea upgraded the stock from Underweight to Equal-Weight. Rockwell Automation shares rose 0.9% to $311.67 in pre-market trading.
Morgan Stanley cut Farfetch Limited FTCH price target from $20 to $5. Morgan Stanley analyst Lauren Schenk downgraded the stock from Overweight to Equal-Weight. Farfetch shares fell 3.8% to close at $2.82 on Monday.
HC Wainwright & Co. boosted ImmunoGen, Inc. IMGN price target from $26 to $27. HC Wainwright & Co. analyst Swayampakula Ramakanth maintained a Buy rating. ImmunoGen shares rose 3% to $16.01 in pre-market trading.
Morgan Stanley lowered the price target for BeiGene, Ltd. BGNE from $321 to $319. Morgan Stanley analyst Matthew Harrison maintained an Overweight rating. BeiGene shares rose 5.2% to $212.50 in pre-market trading.
BMO Capital increased Hersha Hospitality Trust HT price target from $7 to $10. BMO Capital analyst Ari Klein maintained a Market Perform rating. Hersha Hospitality Trust shares fell 0.5% to $9.74 in pre-market trading.
Morgan Stanley cut Kymera Therapeutics, Inc. KYMR price target from $39 to $37. Morgan Stanley analyst James Quigley maintained an Equal-Weight rating. Kymera Therapeutics shares rose 0.1% to close at $19.66 on Monday.